CA
GILD icon

Continuum Advisory’s Gilead Sciences GILD Stock Holding History

Continuum Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Sell
5,971
-37
-0.6% -$4.88K 0.06% 244
2026
Q1 		$837K Buy
6,008
+297
+5% +$41.6K 0.08% 214
2025
Q4 		$701K Buy
5,711
+573
+11% +$69.6K 0.07% 236
2025
Q3 		$570K Buy
5,138
+209
+4% +$23.8K 0.06% 258
2025
Q2 		$546K Buy
4,929
+355
+8% +$37.8K 0.07% 251
2025
Q1 		$513K Sell
4,574
-47
-1% -$4.85K 0.07% 231
2024
Q4 		$427K Sell
4,621
-13
-0.3% -$1.17K 0.05% 265
2024
Q3 		$427K Sell
4,634
-21
-0.5% -$1.6K 0.05% 268
2024
Q2 		$319K Sell
4,655
-442
-9% -$29.5K 0.05% 294
2024
Q1 		$329K Sell
5,097
-8,894
-64% -$684K 0.05% 289
2023
Q4 		$1.13M Buy
13,991
+539
+4% +$41.9K 0.16% 156
2023
Q3 		$1.01M Sell
13,452
-125
-0.9% -$9.62K 0.16% 162
2023
Q2 		$1.05M Sell
13,577
-5,740
-30% -$458K 0.17% 157
2023
Q1 		$1.6M Sell
19,317
-781
-4% -$64.7K 0.27% 105
2022
Q4 		$1.73M Buy
20,098
+764
+4% +$60.5K 0.31% 92
2022
Q3 		$1.19M Buy
19,334
+666
+4% +$42K 0.21% 129
2022
Q2 		$1.15M Buy
18,668
+4,187
+29% +$259K 0.21% 131
2022
Q1 		$859K Buy
+14,481
New +$926K 0.16% 155
2021
Q3 		– Sell
-4,135
Closed -$285K – 299
2021
Q2 		$285K Sell
4,135
-169
-4% -$11.3K 0.09% 217
2021
Q1 		$283K Sell
4,304
-739
-15% -$47.7K 0.12% 141
2020
Q4 		$294K Hold
5,043
– – 0.13% 121
2020
Q3 		$319K Sell
5,043
-1,474
-23% -$102K 0.17% 113
2020
Q2 		$496K Buy
6,517
+1,597
+32% +$122K 0.31% 73
2020
Q1 		$357K Buy
+4,920
New +$340K 0.24% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Continuum Advisory's GILD Position: Q2 2026 in Review

Continuum Advisory reduced its Gilead Sciences (GILD) stake by 0.62% in Q2 2026, selling an estimated $4.88K and leaving 5,971 shares worth $754K. The position accounts for 0.06% of the portfolio, ranked #244.

Continuum Advisory first reported a position in GILD in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.73M in Q4 2022. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Continuum Advisory held 5,971 shares of Gilead Sciences worth $754K as of Q2 2026.
  • Continuum Advisory sold 37 Gilead Sciences shares in Q2 2026, an estimated $4.88K.
  • Gilead Sciences made up 0.06% of Continuum Advisory's portfolio in Q2 2026, its #244 holding.
  • Continuum Advisory first reported a position in Gilead Sciences in Q1 2020 and has held it in 24 quarters since.
  • Continuum Advisory's Gilead Sciences position peaked at $1.73M in Q4 2022.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.